Skip to content

Clinical trials

Phase 1 Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1 Clear all

298 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20034
20042
20057
20064
20076
20089
20099
20108
201115
20128
201310
20147
20158
201614
201715
201815
201913
202020
202122
202219
202323
202418
202515
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed128
Recruiting51
Terminated40
Unknown status23
Active, not recruiting21
Not yet recruiting18
Withdrawn13
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center17
National Cancer Institute (NCI)14
St. Jude Children's Research Hospital7
Acrotech Biopharma Inc.6
City of Hope Medical Center6
AbbVie5
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.5
Bellicum Pharmaceuticals4
Celgene4
Incyte Corporation4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms298
Leukemia, Myeloid, Acute53
Myelodysplastic Syndromes40
Lymphoma38
Leukemia, Lymphocytic, Chronic, B-Cell36
Leukemia35
Multiple Myeloma35
Precursor Cell Lymphoblastic Leukemia-Lymphoma34
Recurrence34
Neoplasms31

Trials

Showing 76 to 100 of 298. Each trial links to its page on Pharma Observatory.

198 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.